Eva Renee Barnett has sold IMVT and made no open-market buys since Jan 2022
CFO at Immunovant, Inc.
SEC CIK 0001883766 · Filings on SEC.gov ↗
$0Bought
$2.7MSold
NoneLast buy
Every filing
19 filings since Jan 2022, newest first
IMVTSell
Immunovant, Inc.
CFO
$106K−1.0%Nov 22
IMVTSell
Immunovant, Inc.
CFO
$94K−1.0%Oct 18
IMVTSell
Immunovant, Inc.
CFO
$153K−2.0%Oct 11
IMVTSell
Immunovant, Inc.
CFO
$120K−1.0%Aug 23
IMVTSell
Immunovant, Inc.
CFO
$93K−1.0%Jul 19
IMVTSell
Immunovant, Inc.
CFO
$133K−1.0%Jul 10
IMVTSell
Immunovant, Inc.
CFO
$120K−1.0%May 24
IMVTSell
Immunovant, Inc.
CFO
$356K−3.0%Apr 19
IMVTSell
Immunovant, Inc.
CFO
$115K−1.0%Apr 10
IMVTSell
Immunovant, Inc.
CFO
$106K−1.0%Feb 23
IMVTSell
Immunovant, Inc.
CFO
$147K−1.0%Jan 12
IMVTSell
Immunovant, Inc.
CFO
$133K−1.0%Nov 24
IMVTSell
Immunovant, Inc.
CFO
$168K−1.0%Oct 11
IMVTSell
Immunovant, Inc.
CFO
$292K−4.0%Aug 25
IMVTSell
Immunovant, Inc.
CFO
$68K−1.0%Jul 20
IMVTSell
Immunovant, Inc.
CFO
$52K−1.0%Apr 19
IMVTSell
Immunovant, Inc.
CFO
$76K−2.0%Jan 13
IMVTSell
Immunovant, Inc.
CFO
$118K−4.0%Oct 13
IMVTSell
Immunovant, Inc.
CFO
$217K−15.0%Jan 11
Filings come from SEC EDGAR. Not investment advice.